Prenatal screening for cystic fibrosis: Where are we now?

Journal of Pediatrics

Volumn 141, Issue 6, 2002, Pages 758-763

  Farrell, Philip M ^a   Fost, Norman ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; PANCREAS ENZYME; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ATTITUDE; AUTOSOMAL RECESSIVE DISORDER; CHLORIDE TRANSPORT; CLINICAL FEATURE; CLINICAL PRACTICE; CYSTIC FIBROSIS; DEATH; DECISION MAKING; DIAGNOSTIC TEST; ELECTROLYTE DISTURBANCE; ENZYME THERAPY; ETHNIC DIFFERENCE; FAMILY HISTORY; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; HEALTH CARE POLICY; HEALTH INSURANCE; HETEROZYGOSITY; HUMAN; INFORMED CONSENT; MALNUTRITION; MEDICAL ETHICS; MOLECULAR GENETICS; NOTE; PANCREAS DISEASE; PANCREAS INSUFFICIENCY; PATIENT INFORMATION; PATIENT SATISFACTION; PHENOTYPE; PRACTICE GUIDELINE; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0036907465     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127666     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development. MMWR Morb Mortal Wkly Rep 1997;46: RR-16.
2. American College of Obstetricians and Gynecologists, American College of Medical Genetics. Preconception and Prenatal Carrier Screening for Cystic Fibrosis. 2001;1-33.
3. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-53.
4. NIH Consensus Development Conference Statement. Genetic testing for cystic fibrosis, April 14-16, 1997. Arch Intern Med 1999;159:1529-39.
5. Karem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 1989;245-1073-80.
6. Kosorok MR, Wei W-H, Farrell PM. The incidence of cystic fibrosis. Stat Med 1996;15:449-62.
7. Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): Comparison of screening protocols. Am J Hum Genet 1993;52:616-26.
8. Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A, et al. Cystic fibrosis heterozygote screening in 5161 pregnant women. Am J Hum Genet 1996;58:823-35.
9. Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic fibrosis: A worldwide analysis for CFTR mutations - Correlation with incidence data and application to screening. Human Mutat 2002;19:575-606.
10. Wood RE. Prognosis. Verlag GT, editor. In: Cystic Fibrosis. New York: Thieme-Stratton, Inc; 1984. p. 434-60.
11. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease - Carrier screening, prenatal diagnosis, and the molecular era: An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 1993;270:2307-15.
12. Mall M, Wissner A, Gonska T, Calenborn D, Kuehn J, Brandis M, et al. Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cyctic fibrosis airways. Am J Respir Cell Mol Biol 2000;23:755-61.
13. Crozier DN. Cystic fibrosis: A not-so-fatal disease. Pediatr Clin North Am 1974;21:935-50.
14. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry Annual Data Report, 2000. Bethesda (MD): Cystic Fibrosis Foundation; 2000.
15. Mérelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment of long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-15.
16. Lai H-C, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol 2002;158:165-73.
17. Welsh MJ, Tsui L, Boat TC, Beaudet AL. The metabolic and molecular bases of inherited disease. 17th ed. In: Shriver CR, Beaudet AL, Sly WS, et al, eds. Cystic Fibrosis. New York: McGraw-Hill; 1995. p. 3799-876.
18. Le Maréchal C, Audrézet MP, Quére I, Raguénes O, Langonné, Férec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): Major implications for genetic counseling. Hum Genet 2001;108:290-8.
19. Doherty RA, Palomaki GE, Kloza EM, Erickson JL, Haddow JE. Couple-based prenatal screening for cystic fibrosis in primary care settings. Prenat Diagn 1996;16:397-404.
20. Grody WW, Desnick RJ. Cystic fibrosis population carrier screening: Here at last - Are we ready? Genet Med 2001;3:87-90.
21. President's Commission for the Study of Ethical Problems in Medicine and Biomedical Research. Screening and Counseling for Genetic Conditions. Washington (DC): US Government Printing Office; 1983.
22. National Institutes of Health. Workshop on population screening for the cystic fibrosis gene. N Engl J Med 1990;323:70-1.
23. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing Genetic Risks: Implications for Health and Social Policy. Washington (DC): National Academy Press; 1994.
24. Cuckle HS, Richardson GA, Sheldon TA, Quirke TA. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 1995;311:1460-4.
25. Modaff M, Biesecker, B. Personal communication. January, 2002.
26. Clayton EW, Hannig PI, Pfotenhauer JP, Parker RA, Campbell PW 3rd, Phillips JA. Teaching about cystic fibrosis carrier screening by using written and video information. Am J Hum Genet 1995;57:171-81.
27. Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, et al. Uptake of cystic fibrosis testing in primary care: Supply push or demand pull? BMJ 1993;306:1584-6.
28. Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, et al, Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998;102:44-52.
29. Grody WW, Dunkel-Schetter C, Tatsugawa ZH. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. Am J Hum Genet 1997;60:935-47.
30. Watson EK, Mayall ES, Lamb J, Chapple J, Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet 1992;340:217-20.
31. Lippman-Hand A, Fraser FC. Genetic counseling: Provision and reception of information. Am J Med Genet 1979;3:113-27.
32. The American College of Obstetricians and Gynecologists. Cystic Fibrosis Carrier Testing: The Decision is Yours. Washington (DC): 2001.
33. Billings PR, Kohn NA, de Cuevas M, Beckwith J, Alper JS, Natowicz MR. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;50:476-82.
34. Alper JS, Geller LN, Barash CI, Billings PR, Laden V, Natowicz MR. Genetic discrimination and screening for hemochromatosis. J Public Health Policy 1994;15:3345-58.
35. Natowicz MR, Alper JK, Alper JS. Genetic discrimination and the law. Am J Hum Genet 1992;50:465-75.
36. Livingstone J, Axton RA, Gilfillan A, Mennie M, Compton M, Liston WA, et al. Antenatal screening for cystic fibrosis: A trail of the couple model. BMJ 1994;308:1459-62.
37. Clayton EW, Hannig VI, Pfotenhauer JP, Parker RA, Campbell PW 3rd, Phillips JA 3rd. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet 1996;58:617-27.
38. Watson EK, Mayall E, Chapple J, Dalziel M, Harrington K, Williams C, et al. Screening for carriers of cystic fibrosis through primary health care services. BMJ 1991;305:504-7.
39. Raeburn S. Screening for carriers of cystic fibrosis. BMJ 1994;308:1451-2.
40. Burn J. Screening for cystic fibrosis in primary care. BMJ 1993;306:1558-9.
41. Asch DA, Hershey JC, Pauly MV, Patton JP, Jedrziewski KM, Mennuti MT. Genetic screening for reproductive planning: Methodological and conceptual issues in policy analysis. Am J Public Health 1996;86:684-90.
42. Kevles DJ. In the Name of Eugenics: Genetics and the Uses of Human Heredity. Cambridge (MA): Harvard University Press; 1995.
43. Haddow JE, Palomaki GE, Glenn E, Bradley LA, Doherty RA. Screening for cystic fibrosis. JAMA 1998;279:1068-9.
44. Bobadilla JL, Farrell MH, Farrell PM. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening. Adv Pediatr 2002;49:131-90.
45. Guilbert F. Cystic fibrosis carrier screening: Steps in the development of a mutation panel. Genet Test 2001;5:223-7.
46. Holtzman NA. Is public health ready for genetics? Arch Pediatr Adolesc Med 2001;155:117-8.